MedTrace Logo

Pilot Study of Hypothermia for Intracerebral Hemorrhage in Croatia

NCT01221142 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2010-12-28

No results posted yet for this study

Summary

In this pilot study the researchers will investigate efficacy of hypothermia in the early stage of treatment patients with primary intracerebral hemorrhage.

Conditions

  • Hypothermia
  • Primary Intracerebral Hemorrhage
  • Signs and Symptoms

Interventions

DEVICE

Cincinnati Sub-Zero," Blanketrol III"

Sponsors & Collaborators

  • PharmamedMado d.o.o., Zagreb, Croatia

    collaborator UNKNOWN

  • University of Rijeka

    lead OTHER

Principal Investigators

  • Igor Antoncic, MD, MSc · Intensive Care Unit, Departmen of Neurology, University Hospital Rijeka, Croatis

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2011-09-30
Completion
2012-06-30

Countries

  • Croatia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01221142 on ClinicalTrials.gov